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        Introduction 
  Cardiomyocytes actively divide during embryonic development 
but exit the cell cycle and stop proliferating shortly after birth 
(  Winick and Noble, 1965  ;   Li et al., 1996  ;   Burton et al., 1999  ). 
The incapacity of adult cardiomyocytes to divide underlies the 
inability of the heart muscle to regenerate after an injury, such 
as a myocardial infarction, that frequently leads to overload and 
heart failure. Notch signaling is normally active in the embry-
onic heart of multiple species, where it infl  uences cell fate and 
morphogenesis, including within the early myocardial fi  eld, 
atrioventricular canal myocardium and cushions, and in the ven-
tricular wall (  Rones et al., 2000  ;   Loomes et al., 2002  ;   Rutenberg 
et al., 2006  ;   Watanabe et al., 2006  ;   Grego-Bessa et al., 2007  ; 
  Niessen and Karsan, 2007  ). In addition to controlling cell fate, 
several studies indicate that Notch infl  uences tissue formation 
and morphogenesis during development by regulating the bal-
ance between a progenitor or precursor pool and differentiating 
progeny (  Dallas et al., 2005  ;   Fre et al., 2005  ;   Mammucari et al., 
2005  ;   van Es et al., 2005  ). In principal, a similar process could 
contribute to tissue regeneration (  Kohler et al., 2004  ;   Raya et al., 
2004  ;   Su et al., 2006  ;   Nakamura and Chiba, 2007  ;   Poss, 2007  ). 
Because the signals that control fetal and early neonatal cardio-
myocyte replication and the subsequent postnatal withdrawal 
from cell cycle are unclear, we explored whether Notch reacti-
vation might trigger and sustain the cell cycle of neonatal divid-
ing and quiescent cardiomyocytes. 
  Binding to the transmembrane Delta or Jagged ligands on 
a signaling cell triggers a    -secretase – dependent  proteolytic 
cleavage of transmembrane Notch receptors on the responding 
cell (  Schweisguth, 2004  ). Cleavage releases the Notch intracel-
lular domain (ICD) that complexes with the transcription factor 
recombination signal-binding protein 1 for J     (RBP-J  ;  also 
known as CSL [CBF1, Su(H), LAG-1]) to activate transcription 
of downstream targets. In addition to this canonical cascade, 
RBP-J      –  independent signaling has recently been demonstrated 
T
he inability of heart muscle to regenerate by repli-
cation of existing cardiomyocytes has engendered 
considerable interest in identifying developmental 
or other stimuli capable of sustaining the proliferative 
capacity of immature cardiomyocytes or stimulating 
division of postmitotic cardiomyocytes. Here, we demon-
strate that reactivation of Notch signaling causes embryonic 
stem cell  –  derived and neonatal ventricular cardiomyocytes 
to enter the cell cycle. The proliferative response of neo-
natal ventricular cardiomyocytes declines as they ma-
ture, such that late activation of Notch triggers the DNA 
damage checkpoint and G2/M interphase arrest. Notch 
induces recombination signal-binding protein 1 for J     
(RBP-J    )-dependent expression of cyclin D1 but, unlike 
other inducers, also shifts its subcellular distribution 
from the cytosol to the nucleus. Nuclear localization of 
cyclin D1 is independent of RBP-J    . Thus, the inﬂ  uence of 
Notch on nucleocytoplasmic localization of cyclin D1 is 
an unanticipated property of the Notch intracellular domain 
that is likely to regulate the cell cycle in multiple con-
texts, including tumorigenesis as well as cardiogenesis.
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  Figure 1.       Activated Notch induces cell cycle reentry in quiescent cardiomyocytes.   (A  –  D) NRVCs were either uninfected (A and E) or infected with Ad-    Gal 
(B and F) or Ad-N2  ICD   (C and G). 48 h after infection, cells were stained with mouse anti-MF20 (green, Alexa 488) and propidium iodide (PI; A  –  C). The 
number of MF20 
+   cells (green, Alexa 488) was   >  90% in all cases. DNA content was analyzed for the MF20 
+   population (insets) and the percentage in 
S/G  2  /M phase for each condition was calculated (D). The examples shown are representative of more than ﬁ  ve experiments with similar outcomes. (E  –  H) 
Examples of NRVCs as in A  –  D stained with MF20 (red, Alexa 594) and Ki67 (green, Alexa 488; E  –  G) 48 h after infection, and the percentage of Ki67 
+   
cells within the MF20 
+   population was measured (H). The examples shown are representative of more than ﬁ  ve experiments with similar outcomes. (I) 12 h 
after infection, NRVCs were transfected with 0.6   μ  g of the pHes1-Luc or p    Hes1-Luc plasmids and 0.2   μ  g pGL3-  Renilla-  Luc. Luciferase activities and protein 
expression of Notch2 and V5 epitope (inset) were determined 12 h later. Fireﬂ  y activity was normalized using   Renilla   luciferase activity. (J) Examples of 
NRVCs as in A  –  D stained with V5 (red, Alexa 594), Notch2, (green, Alexa 488), and DAPI (blue) 48 h after infection. (K) Confocal images showing the 131  NOTCH SUSTAINS CARDIOMYOCYTE CELL CYCLE   • Campa et al. 
persistence of Ki67 
+   (green, Alexa 488) and MF20 
+   (red, Alexa 594) cardiomyocytes in differentiating mESCs expressing N2  ICD   from the MLC2V promoter 
compared with typically quiescent cardiomyocytes in cultures harboring only the REX promoter  –  Bla 
r   gene. Error bars indicate   ±  SD across experimental 
replicates. Bars: (E  –  G and K) 10   μ  m; and (J) 50   μ  m.     
 
to occur through various intermediaries, including the Dishev-
elled (Dsh) protein required for Wnt signaling (  Bush et al., 
2001  ;   Ramain et al., 2001  ). Despite its involvement in tumori-
genesis and tissue morphogenesis, details of the mechanisms 
that might link Notch signaling to cell cycle control are unclear, 
although the complex containing the Notch ICD and RBP-J    
directly activates transcription of the cyclin D1 gene promoter 
(  Ronchini and Capobianco, 2001  ). 
  We found that activation of the Notch pathway in mouse 
embryonic stem cell (mESC)-derived and early neonatal cardio-
myocytes induced cyclin D expression and stimulated cell cycle 
entry, mitosis, and cell division. Cell cycle progression involved 
the RBP-J      –  dependent induction of cyclin D1, which led to its 
cytosolic accumulation. Translocation to the nucleus, retino-
blastoma protein (Rb) phosphorylation, and cell cycle entry, 
however, specifi  cally required the Notch ICD. This constitutes a 
novel function for the ICD that might account for aspects of 
RBP-J      –  independent signaling that have been implicated re-
cently in tumorigenesis (for reviews see   Leong and Karsan, 
2006  ;   Miele et al., 2006  ). Interestingly, N2  ICD   induced older car-
diomyocytes to enter cell cycle; however, DNA damage check-
point activation and G  2  /M interphase arrest followed, most 
likely refl  ecting an intrinsic barrier to replication of mature car-
diomyocytes that might serve a benefi  cial role in the mature 
heart by preventing mitotic catastrophe and apoptosis in re-
sponse to mitogenic stimuli. Together, these results point to a 
role for Notch in the expansion of cardiomyocyte progenitor or 
precursor pools needed for heart growth during development 
and potentially during regeneration after injury in the adult. 
  Results 
  Notch induces quiescent cardiomyocytes 
to reenter the cell cycle 
  Neonatal rat ventricular cardiomyocytes (NRVCs) normally exit 
the cell cycle and enter G  0   (  Burton et al., 1999  ), but infection with 
a recombinant adenovirus encoding the N2  ICD   (Ad-N2 ICD )  dramat-
ically changed the cell cycle profi  le of cardiomyocytes, increasing 
the percentage of NRVCs in S/G  2  /M phase 2.4-fold 48 h after in-
fection (which corresponds to postnatal day 5 [P5];   Fig. 1, A, 
C, and D ). In contrast, control NRVCs infected with an adenovirus 
encoding    -galactosidase  (Ad-   Gal) had no effect over back-
ground ( Fig. 1, B and D ). Ad-N2  ICD  also increased the incidence of 
Ki67 
+   NRVCs nearly 10-fold (  Fig. 1, E, G, and H  ), whereas Ad-
    Gal had no signifi  cant effect (  Fig. 1 F  ). Notch signaling was con-
fi  rmed by the induction of hairy and enhancer of split 1 (Hes1) 
promoter – dependent luciferase activity in Ad-N2  ICD  – infected cells 
(  Fig. 1 I  ) and the expression of high levels of recombinant N2  ICD  
(V5-tagged) protein in the nuclei of Ad-N2  ICD  – infected  cardio-
myocytes (  Fig. 1 I  , inset; and   Fig. 1 J  ). Endogenous Notch2 in 
cardiomyocytes declined postnatally (not depicted) such that it 
was no longer detectable by P5 (  Fig. 1 J  ), which indicates that 
exogenous reactivation of Notch2 can direct cell cycle entry. 
  Similarly, mESC lines were created with a dual-cassette 
vector that produced N2  ICD   under control of the ventricular car-
diomyocyte-specifi  c myosin light chain 2V (MLC2V) promoter 
and the blastocidin 
r   gene for drug selection from the stem cell 
promoter Rex. N2  ICD   showed extended replicative capacity of 
cardiomyocytes to at least day 21 after initiation of differentia-
tion, yielding overgrowths in the cultures (  Fig. 1 K  ), whereas 
control mESCs harboring only Rex-Bla 
r   showed the normal 
cessation of cell division by day 12  –  16. 
  Notch2  ICD   induces expression and nuclear 
translocation of cyclin D1 
  Neonatal mouse ventricular cardiomyocytes (NMVCs) were 
prepared from RBP-J    
Flox/Flox   mice to probe whether cell cycle 
reentry required RBP-J    . Excision of exons 6 and 7 of RBP-J    
by Cre recombinase eliminates function (  Tanigaki et al., 2002  ), 
and introduction of a Cre-EGFP fusion protein blocked the abil-
ity of N2  ICD   to stimulate cell cycle reentry, demonstrating the 
dependence on RBP-J     ( Fig.  2 ). 
  A potential transcriptional target of RBP-J     is cyclin D1. 
Cyclin D1 and other D-type cyclins (D2 and D3) translocate to 
the nucleus, where they function with Cdk4 and 6 to phosphory-
late Rb and cause progression through the cell division cycle 
(  DeGregori, 2004  ). A time-dependant up-regulation of cyclin 
D1 was apparent beginning    6 – 9  h  after  Ad-N2 ICD   infection 
(  Fig. 3 B  ). Cyclin D1 induction precedes cell cycle entry (  Fig. 3 A  ) 
by     24 h, which correlates well with the duration of G  1   phase 
observed for rat cells (i.e., 24 h in primary cultures of endothe-
lial cells;   Solodushko and Fouty, 2007  ). Also, the level of the 
G  1  /S-phase cyclin, cyclin E, increased at 36 h (  Fig. 3 C  ), which 
correlates with the observed cell cycle profi  le (  Fig. 3 A  ) and 
confi  rms the S-phase entry of NRVCs. 
  Although low serum was included in the preceding exper-
iments to enhance cell survival, its absence did not prevent cell 
cycle reentry by N2  ICD   (18.3% S+G  2  +M phase cells in unin-
fected cells vs. 44.4% in infected cells), which indicates that 
Notch-induced cell cycle reentry is independent of serum fac-
tors, consistent with induction of cyclin D1 by RBP-J   .  More-
over, even high (10%) serum was insuffi  cient to stimulate cell 
cycle entry, see the following paragraph. 
  Cyclin D1 levels were elevated within the nuclei of Ad-
N2  ICD    –  infected NRVCs, visualized by coimmunofl  uorescent stain-
ing with the V5 epitope on N2  ICD  , but were absent in nuclei of 
control Ad-   Gal  –  infected NRVCs (arrows indicate examples in 
  Fig. 3 D  ). Nuclear localization of cyclin D1 was accompanied 
by phosphorylation of Rb at Ser807/811, Ser795, and Ser 780 in 
extracts prepared with 10 mM EDTA to inhibit kinase activity 
after lysis ( Fig. 3 E , right). Although phenylephrine (PHE) and 10% 
FCS induced cyclin D1 (  Fig. 3, E and G  ), both failed to stimulate 
its characteristic nuclear localization (  Fig. 3 G  , inset, arrowhead 
in the N2  ICD   panel indicates a characteristic nuclear pattern), Rb 
phosphorylation (  Fig. 3, E  –  G  ) or DNA synthesis (Fig. S1, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200806104/DC1). JCB • VOLUME 183 • NUMBER 1 • 2008  132
the characteristic cytoplasmic and perinuclear localization of cy-
clin D1 (  Fig. 5 B  ), whereas Ad-N2ICD (  Fig. 5 B  ) and the sequen-
tial treatment with Ad-Cre-EGFP and Ad-N2ICD (  Fig. 5, 
C and D  ) both induced nuclear localization. Closed arrows (  Fig. 
5 D  ) indicate examples of Cre-EGFP 
+ ,  N2 ICD  
+   cells with nuclear 
localization of cyclin D1. Prominent nuclear expression of cyclin 
D1 was seen in the rare cells that expressed N2  ICD   but had not re-
ceived Cre-EGFP (indicated by open arrows). In contrast, cyclin 
D1 was cytoplasmic and perinuclear in cells that had Cre-EGFP 
but did not express N2  ICD   (  Fig. 5 D  , indicated by asterisks). Col-
lectively, RBP-J     is required for Notch to induce cyclin D1 tran-
scription but not for nuclear localization. 
  Notch-regulated nuclear export versus 
import of cyclin D1 
  Nuclear localization of cyclin D1 is controlled by a fi  ne balance 
between import, through an unknown mechanism, and export 
through the chromosome region maintenance 1 (CRM1)/export-
in-1 transporter. Cyclin D1 phosphorylation by glycogen synthase 
kinase-3     (GSK3  )  at  Thr 286   is thought to trigger export to the 
cytosol and degradation by the proteasome (  Diehl et al., 1998  ). 
  To test if N2  ICD   regulates export, we fi  rst compared its ac-
tion to 6-bromoindirubin-3    -oxime (BIO), a small molecule 
inhibitor of GSK3    . BIO induced cell cycle reentry in a dose-
dependent manner, albeit less dramatically than what is seen with 
N2  ICD   (  Fig. 6 A  ), as previously described (  Tseng et al., 2006  ). 
The inactive control compound MetBIO failed to promote cell 
cycle reentry of NRVCs. BIO, but not MetBIO, also caused 
nuclear accumulation of cyclin D1 ( Fig. 6, B – D ) and phosphory-
lation of nuclear Rb (  Fig. 6, E  –  G  ), which is suggestive that 
retention of cyclin D1 in the nucleus contributes to cell cycle 
entry by BIO. 
  Unlike BIO, N2  ICD   did not inhibit GSK3    , which was de-
termined by monitoring luciferase activity from the T cell factor –
  dependent luciferase activity from the pTOPfl  ash  reporter 
Lysates prepared in the absence of EDTA to preserve kinase 
activity after dissolution of the cell membranes showed that 
PHE or FCS can stimulate Cdk activity (  Fig. 3 E  , left). Because 
Rb phosphorylation occurred under these conditions but not in 
the presence of EDTA, we concluded that PHE and FCS alone 
cannot stimulate Rb phosphorylation because the components 
are not colocalized in the nucleus. This raises the possibility 
that the N2  ICD   might have a unique role in localizing the cyclin 
D1  –  Cdk complex to the nucleus. 
  Cyclin D1 nuclear localization requires 
notch ICD 
  To distinguish induction of cyclin D1 gene expression from 
nuclear localization, we transfected NRVCs to express a consti-
tutively active form of RBP-J     made by fusion to the VP16 
transactivation domain and a MYC epitope tag (pRBP-J   -
VP16). RBP-J    -VP16 activates transcription of Notch-dependent 
genes, including pHes1-luciferase in cardiomyocytes (  Fig. 
4 F  ). RBP-J    -VP16 induced the accumulation of cyclin D1 in 
the cytosol but not in the nucleus, as had been seen with N2  ICD  
( Fig.  4,  A – C  ), and did not stimulate cell cycle entry (  Fig. 4 E  ), 
which confi  rms that elevated cyclin D1 expression is insuffi  -
cient to promote cell cycle entry. As a control, a DNA-binding 
mutant (DBM) control of RBP-J     (pRBP-J   -DBM) that does 
not activate pHes1-luciferase (  Fig. 3 F  ) did not induce cyclin 
D1 (  Fig. 4 D  ). PHE or 10% FCS also induced only cytosolic 
accumulation of cyclin D1 (  Fig. 3 G  ). The failure of activated 
RBP-J    , PHE, or 10% FCS to localize cyclin D1 to the nucleus 
indicated a specifi  c requirement for N2  ICD . 
 N2 ICD   also stimulated nuclear localization of cyclin D1 in 
RBP-J    
Flox/Flox   NMVCs after Cre excision (  Fig. 5  ). Ad-Cre-EGFP 
on P1 effectively excised RBP-J     1 d later (  Fig. 5, A and E  ). As 
shown in   Fig. 2  , N2  ICD   cannot induce cyclin D1 in the absence of 
RBP-J    , therefore 10% FCS was added 1 d before harvesting the 
cells to induce cyclin D1 ( Fig. 5 A ). Ad-  gal – treated cells showed 
  Figure 2.       Cell cycle reentry requires RBP-J    .   (A) Examples of RBP-J     
Flox/Flox   NMVCs infected with Ad-Cre-EGFP to remove RBP-J    , then reinfected 12 h 
later with Ad-N2  ICD  , as indicated, cultured 48 h, and stained with MF20 (red, Alexa 594), Ki67 (far red, Cy5, shown as green), and DAPI (blue). Arrows 
indicate Ki67 
+   cells. Bar, 10   μ  m. (B) The percentage of Ki67 
+   cardiomyocytes (MF20 
+  ) in each condition. Only Cre-expressing cells (GFP 
+  , green) were 
counted in cultures infected with Ad-Cre-EGFP. N2  ICD   induced KI67 (P = 0.05) but the N2  ICD   effect following Cre was not signiﬁ  cantly different from that of 
Cre alone (ns). Error bars indicate   ±  SD across experimental replicates.     133  NOTCH SUSTAINS CARDIOMYOCYTE CELL CYCLE   • Campa et al. 
tion of CRM1/exportin-1 inhibition prevents cell cycle progres-
sion (  Yoshida et al., 1990  ). The results with LMB, together with 
the lack of an inhibitory effect of N2  ICD   on GSK3     or the phos-
phorylation of cyclin D1, suggest that N2  ICD   does not control 
export or degradation but might stimulate nuclear import. 
  Activation of the DNA damage checkpoint 
in older NRVCs 
  Activated Notch effectively stimulated P2 NRVCs to enter 
mitosis, as revealed by phosphorylation of histone 3 (His3) on 
Ser  10   (62.1% phospho-Ser  10 -His3 
+   in  AdN2 ICD -infected  P2 
NRVCs vs. 44.5% for uninfected; P   <   0.001, two-tailed Stu-
dent ’ s   t   test). The presence of phospho-Ser  10   is a hallmark for 
entry into mitosis and is required for chromatin condensation 
(e.g.,   Adams et al., 2001  ;   Crosio et al., 2002  ). In striking con-
trast, older P5 NRVCs completely failed to phosphorylate His3 
(0.57% phospho-Ser  10 -His3 
+  ;   Fig. 7, H and I  ), which revealed a 
postnatal decline in the ability to traverse the G  2 /M  interphase. 
plasmid that senses stabilized     -catenin, a direct target of 
GSK3     (  Fig. 6 H  ). Moreover, the levels of phospho  –  Thr  286  –
 cyclin D1 levels were not inhibited in Ad-N2  ICD –  infected NRVCs 
but were in fact up-regulated compared with controls and, more 
importantly, with PHE- or 10% FCS-treated NRVCs, which also 
expressed high levels of Cyclin D1 (  Fig. 6 I  ). The increase in 
phospho – Thr 286    –  cyclin D1 correlated with increased levels 
of nuclear cyclin D1 available for phosphorylation by GSK3   . 
  As an independent test for regulated export, cells were 
treated with leptomycin B (LMB) to specifi  cally inhibit CRM1/
exportin-1. LMB enhanced nuclear localization of cyclin D1 
beyond that achieved by N2  ICD   alone (  Fig. 6 J  ). Furthermore, 
LMB stimulated nuclear cyclin D1 only in cells that expressed 
N2  ICD   and not in control, uninfected cells (compare N2  ICD  
+   cells 
[  Fig. 6 J  , indicated by arrows] to uninfected cells [  Fig. 6 J  , indi-
cated by circles]). These data are consistent with the idea that 
N2  ICD  acts upstream of CRM1/exportin-1. LMB did not increase 
the number of S/G  2  /M cells (unpublished data) because inhibi-
  Figure 3.       Notch induces expression and nuclear localization of cyclin D1 and phosphorylation of Rb before cell cycle reentry.   (A) The DNA content of the 
cardiac cells analyzed by ﬂ  ow cytometry (as in   Fig. 1  ) at the indicated times after infection. One of two experiments with similar outcomes is shown. 
(B) Cyclin D1 and V5 epitope (N2  ICD  ) expression in NRVCs infected with Ad-N2  ICD   at the indicated times after infection. (C) Time course of cyclin E expres-
sion after Ad-N2  ICD   infection of NRVCs. (D) Examples of nuclear localization of cyclin D1 (arrows) in NRVCs infected with Ad-N2  ICD   as compared with 
Ad-    Gal  –  infected control cultures 48 h after infection. Immunostaining is shown for cyclin D1 (green, Alexa 488), MF20 (red, Alexa 594), V5 epitope 
tag on N2  ICD   (far red, Cy5, shown as green), and DAPI (blue). Confocal microscopic images (insets) conﬁ  rmed nuclear localization. (E) Phosphorylation 
status of Rb in NRVCs 30 h after infection with Ad-N2  ICD   or 24 h after treatment with 10% FCS or 20   μ  M PHE. 5 mM EDTA in the lysis buffer prevents 
phosphorylation from occurring in the lysates. N2  ICD   (V5 epitope), cyclin D1, phospho-Rb (Ser807/811, Ser795, and Ser780), Cdk4, Cdk6, and 
phospho-Cdc6 expression are shown. (F) Incidence of phospho-Rb (Ser807/811) in NRVC cardiomyocytes (MF20 
+   cells). Note that only N2  ICD   induced 
signiﬁ  cant levels of phospho-Rb. Error bars indicate   ±  SD. (G) Immunostaining with MF20 (red, Alexa 594) and for phospho-Rb (Ser807/811; green, 
Alexa 488) or cyclin D1 (green, Alexa 488). Note that cyclin D1 and phospho-Rb are present in the nuclei of N2  ICD  -expressing cells (arrow) but not in 
the nuclei of cells cultured with high serum or PHE. Higher-magniﬁ  cation images are shown in insets with DAPI staining (blue). Bars: (D) 10   μ  m; (G, top) 
50   μ  m; (G, bottom) 10   μ  m.     JCB • VOLUME 183 • NUMBER 1 • 2008  134
percentage of cardiomyocytes in S/G  2 /M phase ( Fig. 7 A ), which 
is suggestive of the fact that cells were already arrested at this 
point. To test this idea, the nocodazole was washed out during 
the last 12 h of culture. Normally, cycling cells resume progres-
sion after removal of nocodazole; however, this had no effect on 
the P5 NRVCs, which indicates that they were likely arrested at 
or before G  2  /M. In contrast, the residual noncardiomyocytes 
(MF20 
      cells) in the preparations arrested at G  2  /M upon no-
codazole treatment and were released by its removal (  Fig. 7 B  ), 
which demonstrates that the Notch-induced block was specifi  c 
to the cardiomyocytes in the cell preparation. 
  AuroraB directly phosphorylates Ser  10   of His3. As shown 
in   Fig.  7  (C – I) ,  Ad-N2 ICD   dramatically increased AuroraB 
A similar postnatal decline in cell division was noted by   Collesi 
et al. (see p.   117   of this issue)   in response to stimulation by ex-
ogenous Jagged. 
  To understand the nature of the block, we probed the cell 
cycle status of treated cells using the DNA polymerase inhibitor 
aphidicolin or the mitotic spindle assembly inhibitor nocodazole 
for various times to block the cell cycle (see   Fig. 7 A  , inset, for 
experimental design). As expected, aphidicolin, which blocks 
cells at the G  1 /S interphase, reduced the percentage of Ad-N2  ICD  –
  expressing NRVCs that had progressed into S, G  2  , or M phases 
of the cell cycle (  Fig. 7 A  ), confi  rming entry into S phase. 
Nocodazole interferes with microtubules and causes cells to arrest 
at the G  2  /M interphase. Importantly, nocodazole did not alter the 
  Figure 4.       RBP-J     is insufﬁ   cient to promote 
nuclear localization of cyclin D1.   (A and B) 
Examples of NRVCs were transfected with 
0.8   μ  g of plasmids encoding a myc epitope-
tagged, constitutively active version of RBP-J     
in pCDNA3 (pRBP-J    -VP16; A) or infected 
with Ad-N2  ICD   (B) and stained 48 h later for 
cyclin D1 (green, Alexa 488), c-myc epitope 
(red, Alexa 594), MF20 (red, Alexa 594), and 
DAPI (blue). Note the absence of nuclear local-
ized cyclin D1 in c-myc 
+   (RBP-J    -VP16 
+  ) cells. 
Circles indicate nuclear regions and arrows 
indicate nuclear localized cyclin D1. (C) Per-
centage of cardiomyocytes treated as in A and 
B showing nuclear versus cytosolic localiza-
tion of cyclin D1. Error bars indicate   ±  SD. 
(D) NRVCs transfected to express a control 
DNA-binding mutant of RBP-J     (pRBP-J    -DBM) 
and stained as in A. Only a basal level of 
cyclin D1 was detected. Circles indicate nuclear 
regions. (E) Percentage of c-myc 
+  /Ki67 
+   (trans-
fected) and c-myc 
     /Ki67 
+   (untransfected) cells 
for pRBP-J    -VP16 (  n   = 69 and 107, respectively) 
and pRBP-J    -DBM (  n   = 57 and 106, respec-
tively) as compared with Ad-N2  ICD   infected 
(  n   = 100); results are representative of four 
trials. (F) RBP-J     and N2  ICD   (0.5   μ  g of plasmid 
per transfection), as in A  –  E, showed expected 
activities on the pHes1-luciferase reporter 
(0.25   μ  g of plasmid per transfection); results 
are representative of two trials. Bars, 5   μ  m.     135  NOTCH SUSTAINS CARDIOMYOCYTE CELL CYCLE   • Campa et al. 
mitosis and resulted in cell death, visualized by an 87-fold increase 
in the number of TUNEL-positive cardiomyocytes ( Fig. 8, I and J ), 
which is consistent with induction of programmed cell death when 
the checkpoint is overridden in cells with DNA replication defects 
(  Belka, 2006  ). The mitosis-inducing kinase Cdc2 is a key compo-
nent of the DNA damage checkpoint pathway downstream of 
ATM/ATR and Chk1, and it shows inhibitory Tyr  15   phosphory-
lation with checkpoint activation.   Fig. 8 K   shows an increase in 
phospho-Tyr  15  -Cdc2 in N2  ICD  -stimulated NRVCs, as well as a 
possible increase in the total Cdc2 protein levels, providing further 
evidence of DNA damage checkpoint activation after the N2  ICD -
induced cell cycle. As expected, phospho-Tyr  15  -Cdc2 returned to 
basal levels after caffeine treatment of N2  ICD -stimulated P5 cardio-
myocytes. We conclude that activation of DNA damage check-
point causes the G  2  /M arrest and is triggered as a consequence of 
improper or incomplete DNA synthesis during S phase. 
expression in the nuclei of P5 NRVCs but completely failed to 
induce His3 Ser  10   phosphorylation in control uninfected or Ad-
    Gal  –  infected NRVCs. A blockade at the level of AuroraB con-
fi  rmed the G  2  /M arrest and suggested activation of the DNA 
damage checkpoint. 
  Caffeine effectively overrides DNA damage G  2 /M  check-
point activation and can permit entry of arrested cells into M phase 
by inhibiting the ataxia telangiectasia mutated (ATM) and ATM 
and Rad-3 related (ATR) kinases, and most likely other DNA 
checkpoint components (e.g.,   Kastan et al., 1991  ;   Sarkaria et al., 
1999  ). Entry into M phase in the presence of caffeine is therefore 
diagnostic of checkpoint activation. Caffeine treatment alone did 
not increase the level of phospho-Ser  10  -His3 in uninfected P5 
NRVCs and in fact caused a minor reduction (  Fig. 8, A  –  E  ). 
In contrast, N2  ICD  increased the number of phospho-His3+ NRVCs 
by 3.5-fold. Overriding checkpoint activation pushed cells into 
  Figure 5.       Nuclear localization of cyclin D1 is RBP-
J     independent.   (A) NMVCs were isolated from RBP-
J     
Flox/Flox   pups on the day of birth (P1) and treated as 
indicated until processing for immunostaining (the 
equivalent of P6). 10% FCS was added to induce 
cyclin D1 in the absence of RBP-Jk. (B  –  D) Confocal 
images of NMVCs showing nuclear localization of 
cyclin D1 (green, Alexa 568;   “  a  ”   and   “  b  ”   panels) 
overlapping with DAPI (blue;   “  a  ”   panels).     -actinin cy-
tosolic immunostaining identiﬁ  ed cardiomyocytes, and 
nuclear V5 epitope immunostaining identiﬁ  ed cells ex-
pressing transduced N2  ICD   (both visualized with a far 
red [Alexa 680] secondary antibody and shown as 
red in   “  c  ”   panels). EGFP (D, d) shows Cre-EGFP fusion 
protein expression. Closed arrows indicate examples 
of Cre-EGFP 
+  , N2  ICD   
+   cells with nuclear localization of 
cyclin D1. Open arrows indicate the rare cells that ex-
pressed N2  ICD   but did not express Cre-EGFP; note the 
prominent nuclear presence of cyclin D1. The asterisks 
indicate a cell that expressed Cre-EGFP but not N2  ICD  ; 
note that cyclin D1 was cytoplasmic and perinuclear. 
(E) RBP-J     protein expression 1 and 3 d after Ad-Cre-
EGFP treatment (corresponding to P3 and P5), show-
ing efﬁ  cient depletion by Cre.     JCB • VOLUME 183 • NUMBER 1 • 2008  136
ing early postnatal development could explain the results of 
  Tamamori-Adachi et al. (2003)  , who showed that although ec-
topically expressed cyclin D1 accumulates in the nucleus of 
still-proliferating fetal cardiomyocytes, it is sequestered in the 
cytoplasm of normally quiescent NRVCs. Moreover, fusion to a 
nuclear localization sequence that targeted cyclin D1 to the nu-
cleus was suffi  cient to induce Rb phosphorylation and cell cycle 
reentry of quiescent NRVCs. 
  The localization of cyclin D1 to the nucleus probably occurs 
as a balance between import, for which the mechanism is poorly 
understood, and regulated export of phospho  –  Thr  286  – cyclin  D1 
through the transporter CRM1 into the cytosol, where it is degraded 
by the proteosome (  Diehl et al., 1998  ). Two lines of evidence indi-
cate that N2  ICD   acts upstream of export: fi  rst, we noted a super-
accumulation of cyclin D1 in the presence of N2  ICD   and LMB, 
which inhibits CRM1-mediated export, indicating that N2  ICD   acts 
upstream of CRM1. Second, N2  ICD   did not modulate GSK3     activ-
ity nor reduce the levels of phospho  –  Thr  286    –  cyclin D1, as did BIO. 
Thus, inhibition of export seems unlikely to be responsible for 
N2  ICD  -directed nuclear accumulation of cyclin D1, and we favor 
the model in which N2  ICD   regulates import. In contrast, BIO itself 
is suffi  cient to promote cardiomyocyte cell cycle entry (  Tseng 
et al., 2006  ), and we propose that inhibition of cyclin D1 Thr  286  
  Discussion 
  We found that cell cycle entry of mESC-derived and quiescent 
cardiomyocytes could be profoundly enhanced by Notch activa-
tion, which controlled expression and nuclear localization of 
cyclin D1. Transcriptional induction of the cyclin D1 gene re-
quired canonical Notch signaling through RBP-J    . Nuclear lo-
calization however was a distinct property of the Notch ICD 
that is essential for cell cycle entry (  Fig. 9  ). The implications of 
these fi  ndings for regulating expansion of cardiomyogenic pro-
genitor or precursor cells and in the control of other normal and 
pathological processes, such as tumorigenesis, are discussed in 
the following paragraphs. 
  Notch and cardiomyocyte cell cycle reentry 
 Our  fi  nding that RBP-J    – dependent  Notch  signaling  induced 
expression of cyclin D1 in quiescent cardiomyocytes is consis-
tent with the presence of a functional RBP-J    – binding  site  in 
the cyclin D1 promoter (  Ronchini and Capobianco, 2001  ). FCS 
and PHE also induced cyclin D1 and, like activated RBP-J   , 
were insuffi  cient to promote nuclear translocation and cell cycle 
reentry. Nuclear localization of cyclin D1 by Notch ICD cou-
pled with the developmental decline in endogenous Notch dur-
  Figure 6.       Notch-induced nuclear accumulation of cyclin D1 in NRVCs is not caused by inhibition of export.   (A) NRVCs were treated for 36 h with the 
GSK3     inhibitor BIO or control MetBIO before staining with MF20 and analysis of DNA content of cardiomyocytes (MF20 
+   population) by ﬂ  ow cytometry, 
as for   Fig. 1  . One of two experiments with identical outcomes is shown. (B  –  G) NRVCs were treated for 24 h with the indicated concentrations of BIO 
(B, C, E, and F) or MetBIO (D and G) before staining with MF20 (red, Alexa 594) and for cyclin D1 (green, Alexa 488; B  –  D) or phospho-Rb (Ser807/811; 
green, Alexa 488; E  –  G). BIO induced both nuclear accumulation of cyclin D1 and phosphorylation of Rb. (H) Ad-N2  ICD    –  infected or control NRVCs were 
transfected with 0.6   μ  g pTopFlash-tk-Luc or pGL3-tk-Luc, as indicated, and 0.2   μ  g of pGL3-  Renilla-  Luc before exposure with BIO (0.25   μ  M, 0.5   μ  M, or 
1   μ  M) for an additional 36 h before luciferase activities were determined. Fireﬂ  y luciferase activity was normalized using   Renilla   luciferase activity. N2  ICD   
did not modulate the     -catenin/T cell factor  –  dependent transcription. Error bars indicate   ±  SD. (I) Total and phospho  –  Thr  286    –  cyclin D1 in NRVCs infected 
with Ad-N2  ICD   or treated with 10% FCS or PHE (20   μ  M). N2  ICD   did not prevent Thr  286   phosphorylation of cyclin D1. (J) LMB enhanced nuclear localization of 
cyclin D1 (green, Alexa 488) by N2  ICD   (red, Alexa 594; arrows) but did not act on uninfected cells (circled nuclei), which is consistent with N2  ICD   regulating 
nuclear localization upstream of export by the CRM1  –  exportin-1 complex. Bars: (B  –  D) 10   μ  m; (E  –  G) 25   μ  m; (J) 10   μ  m.     137  NOTCH SUSTAINS CARDIOMYOCYTE CELL CYCLE   • Campa et al. 
cells, but activated Notch is seen in several tumors, such as breast, 
colon, and pancreas (  Miyamoto et al., 2003  ;  van  Es  et al., 2005 ; 
  Stylianou et al., 2006  ), and it will be interesting to evaluate 
whether it controls cyclin D1 traffi  cking in cancers. 
  Progression through the cell cycle: 
implications of the neonatal decline in 
mitotic response to Notch 
  Between days 4 and 7 after birth, NRVCs lose most of their abil-
ity to respond to exogenous Notch, fi  rst because of the decline in 
Notch 1 and Notch 2 receptors (unpublished data;   Collesi et al., 
2008  ) but also because of a pronounced activation of DNA dam-
age checkpoint in response to activated Notch (  Fig. 8  ). As ex-
pected, overriding the checkpoint pushed the cardiomyocytes into 
mitosis, resulting in mitotic catastrophe and apoptosis. 
phosphorylation, leading to protein stabilization and nuclear local-
ization, is the likely mechanism. 
  How might the Notch ICD promote nuclear translocation? 
We did not detect a physical interaction between N2  ICD   and cy-
clin D1, Cdk4, or Cdk6 by coimmunoprecipitation from NRVCs 
(unpublished data). Moreover, the spatially localized immuno-
staining pattern of cyclin D1 within the nucleus differed from the 
diffuse pattern seen for N2  ICD   or its V5 epitope tag; thus, Notch 
might not participate directly in a cyclin D complex. In termi-
nally differentiated neurons, cyclin D1 becomes cytoplasmic, 
and forced expression of p21 
WAF1   (Cip1) induces nuclear accu-
mulation (  Sumrejkanchanakij et al., 2003  ), so one possibility is 
that Notch modulates the interaction of cyclin D1 with proteins 
such as p21. Little is known about the mechanism that keeps 
cyclin D1 from entering the nuclei of terminally differentiated 
  Figure 7.       Ad-N2  ICD    –  infected NRVCs arrest at the G  2  /M interphase.   (A and B) 3 d after birth, NRVCs were infected with Ad-N2  ICD   or Ad-    -gal, or not 
infected, and, 12 h later, treated with aphidicolin or nocodazole for an additional 36, 48, or 60 h. For nocodazole+ release, nocodazole was removed 
during the last 12 h of culture (see schematic in A, top). The percentages of cells in S/G  2  /M phase in MF20 
+   (cardiomyocytes; A) and MF20 
      (noncar-
diomyocytes; B) populations were determined from ﬂ  ow cytometry. Nocodazole did not increase the incidence of G  2  /M cells among the N2  ICD  -treated 
cardiomyocyte population, which is indicative of a block at the onset of M phase. The example shown is representative of four experiments with similar 
outcomes. (C  –  I) NRVCs were either left uninfected (C and F) or infected with Ad-    Gal (D and G) or Ad-N2  ICD   (E and H), cultured for 48 h, then stained 
with MF20 (red, Alexa 594) and for AuroraB (green, Alexa 488; C  –  E) or for phospho-His3 (Ser10; green, Alexa 488; F  –  H). The percentages of positive 
cells within the MF20 
+   population was then determined (I). Nuclear-localized AuroraB but not phospho-His3 was detected in response to N2  ICD  . Error bars 
indicate   ±  SD. Bar, 25   μ  m.     JCB • VOLUME 183 • NUMBER 1 • 2008  138
  Although most cardiomyocytes after P3  –  5 arrested at 
the G  2  /M interphase, a minor fraction of Ad-N2  ICD  – infected 
NRVCs could be found at all mitotic phases, including cytoki-
nesis (Fig. S2, available at http://www.jcb.org/cgi/content/full/
jcb.200806104/DC1); however, the incidence was the same as 
in uninfected NRVCs. The complex structure of sarcomeric ap-
paratus has been proposed to block chromosomal segregation 
and cytokinesis should mature cardiomyocytes be stimulated 
to reenter in the cell cycle (  Li et al., 1997  ;   Ahuja et al., 2004  ). 
The normally striated staining of MF20 in nondividing cardio-
myocytes (see G  0   and G  1   in Fig. S2 A) was diffuse in the divid-
ing cells, and the distinction of whether dividing cells underwent 
some degree of disassembly or refl  ected a less mature subpopu-
lation should be investigated. The dividing cardiomyocytes showed 
normal hallmarks of M phase. For instance, AuroraB was asso-
ciated with chromosomes during anaphase and localized at the 
midbody during cytokinesis (Fig. S2, B and C), as expected for 
dividing cells. Regulation of p21 
WAF1/Cip1   and p57 
Kip2   also ap-
peared normal. p21 
WAF1/Cip1   was expressed normally in the nuclei 
of both Ki67 
+   and Ki67 
      cells and disappeared during mitosis, 
and the normal expression of p57 
Kip2   also disappeared during 
mitosis (Fig. S2, D  –  F). Interestingly, once the nuclear membrane 
 Several studies have shown that manipulation of cell cycle 
proteins can induce NRVCs to reenter the cell cycle (e.g.,   Agah 
et al., 1997  ;   Huh et al., 2001  ;   Datwyler et al., 2003  ;   Tamamori-
Adachi et al., 2003  ;   Engel et al., 2005  ;   Jung et al., 2005  ;   Tseng 
et al., 2006  ). These studies used reagents (e.g., BrdU incorpora-
tion or Ki67 immunostaining) that refl  ect entry into the cell 
cycle or S phase but not entry into mitosis or cell division. 
Based on our results that DNA damage checkpoint activation 
limits cell division of late-stage quiescent cardiomyocytes, it 
is important to quantitatively evaluate whether treatment with 
these or other reagents can indeed direct cells to enter mitosis 
and divide. 
  Checkpoint activation is not solely a consequence of Notch 
activation. The majority of BIO-treated P5 NRVCs also arrested 
at G  2  /M and showed DNA damage checkpoint activation, as 
demonstrated by caffeine sensitivity and Cdc2 phosphorylation 
(unpublished data). In the context of the adult heart, a benefi  cial 
function of DNA damage checkpoint activation might be to pro-
tect mature cardiomyocytes from apoptosis and cell death after 
exposure to stimuli that support replication of nonmyocytes 
during normal heart function or pathologically as a response to 
injury or remodeling. 
  Figure 8.       DNA damage checkpoint activa-
tion implicated in G  2  /M arrest.   (A  –  E) NRVCs 
were either infected with Ad-N2  ICD   or left un-
infected. 24 h later, 10 mM caffeine (C, D, 
H, and I) or control (A, B, F, and G) media 
were added. Cells were then cultured for an 
additional 24 h, by which time they were 
at P5, and stained with MF20 (red, Alexa 
594) and for phospho-His3 (Ser10; green, 
Alexa488; A  –  D). The incidence of phospho-
His3 
+  , MF20 
+  cardiomyocytes is shown (E). (F  –  J) 
Alternatively, a TUNEL assay (green, ﬂ  uores-
cein) was performed before immunostaining 
with MF20 (red, Alexa594). Note that caffeine 
permitted the induction of phospho-His3 but 
triggered TUNEL reactivity. (K) N2  ICD   (anti-V5 
epitope) and cyclin D1 expression, and the 
corresponding levels of phosphorylated Cdc2 
are shown for NRVCs prepared as in A  –  E. 
Elevated phospho-Cdc2 was observed with 
activated N2  ICD   and reduced by caffeine to 
basal levels, which together is indicative that 
N2  ICD   treatment activates the DNA damage 
checkpoint.     -actinin and nonspeciﬁ  c proteins 
are shown as loading controls. Error bars indi-
cate   ±  SD. Bars, 25   μ  m.     139  NOTCH SUSTAINS CARDIOMYOCYTE CELL CYCLE   • Campa et al. 
eration of a committed precursor or progenitor pool, although 
the origin and prevalence of such cells remains unclear (e.g., 
  Hsieh et al., 2007  ) and a direct role for Notch remains to be 
tested. Regeneration of the adult zebrafi  sh heart is preceded by 
Notch reactivation (  Raya et al., 2003  ). The zebrafi  sh Notch iso-
form characterized as being involved, Notch1b, is expressed by 
endothelial cells of the endocardium rather than by the myocar-
dium, and, therefore, would be expected to infl  uence cardiomyo-
cyte regeneration only indirectly. Thus, whether Notch signaling 
exerts a cell-autonomous effect in regenerating cardiomyocytes 
needs to be resolved using appropriate transgenic models and 
development of specifi  c agonists to stimulate such cells in situ. 
  Materials and methods 
  Cell culture 
  Ventricular cardiomyocytes were isolated with a neonatal rat/mouse cardio-
myocyte isolation kit (Cellutron) and cultured at 37  °  C in humidiﬁ  ed air with 
5% CO  2  . In brief, ventricles were dissected from 1  –  2-d-old Hsd:SD rats 
(Sprage Dawley) or mice, then digested ﬁ  ve times for 15 min each with the 
enzyme cocktail at 37  °  C. Cells were pooled, preplated for 90 min on an 
uncoated dish to remove ﬁ  broblasts, and plated on 1% gelatin-coated cell 
culture plastic dishes in high-serum media (DME/F12 [1:1], 0.2% BSA, 
3 mM sodium-pyruvate, 0.1 mM ascorbic acid, 4 mg/liter transferrin, 2 mM   
L-  glutamine, and 5 mg/liter ciproﬂ  oxacin supplemented with 10% horse se-
rum and 5% FCS) at 1.25   ×   10 
5   cells/cm 
2  . After 24 h, media was changed 
to low-serum medium (same but with 0.25% FCS) and cultured until use. 
Nearly all cardiomyocytes were quiescent by P3. The purity of cultures was 
routinely determined by immunoﬂ   uorescence staining with an anti-muscle 
myosins antibody (MF20; Developmental Biology Hybridoma Bank) and 
Alexa 594  –  conjugated anti  –  mouse immunoglobulin secondary antibodies 
(Invitrogen), and only preps with   >  90% of cardiomyocytes were used for 
analyses. CGR8 mESCs were created by stable HIV lentiviral transduction to 
express Bla 
r   from the Rex promoter and N2  ICD   from the MLC2V promoter 
(  Barcova et al., 2007  ), and embryoid bodies were prepared by removal of 
leukemia inhibitory factor and aggregation in serum-containing medium. 
  Adenoviral infection 
  Ad-N2  ICD   (provided by T. Maciag, Maine Medical Institute, Scarborough, 
ME;   Small et al., 2003  ), Ad-    Gal (Clontech Laboratories, Inc.), and Ad-Cre-
EGFP (a gift from S.V. Kozlov, National Cancer Institute, National Institutes 
of Health, Bethesda, MD) are replication-deﬁ  cient, serotype 5 adenoviruses. 
Viruses were propagated and concentrated using an Adenopure kit (Pure-
syn, Inc.), and viral titers were determined by using the Adeno-X Rapid Titer 
kit (Clontech Laboratories, Inc.). Cardiomyocytes were infected overnight in 
low-serum media at a multiplicity of infection of four to ﬁ  ve viruses per cell. 
The media was replaced 12  –  14 h after infection with fresh low-serum media. 
Optimal titers for infection were determined empirically for each batch of 
virus based on cyclin D1 expression and cell cycle entry. 
  Transfection and luciferase assay 
  Cardiomyocytes were transfected for 6  –  8 h in serum-free media with 0.8   μ  g 
of DNA using Lipofectamine 2000 (Invitrogen) with pHes1-Luc and p    Hes1-
Luc (provided by J. Grifﬁ  n, Dana-Farber Cancer Institute, Boston, MA); 
TOPFlash-tk-Luc (  Luckow and Schutz, 1987  ) and pGL3-tk-Luc (Promega); 
pRS2-RBP-J    -VP16, pRS2-RBP-J    -DBM, pCDN3-RBP-J    -VP16, and pCDN3-
RBP-J    -DBM (  Rutenberg et al., 2006  ); and pRL-tk (Promega) to normalize for 
transfection efﬁ  ciency. The media was replaced after transfection with fresh 
low-serum media and cultured for 36 h before staining or determination of 
luciferase activities using the Dual-Luciferase system (Promega). For the engi-
neered RBP-J    -VP16 and DBM variants, the results were similar whether the 
promoter used was cytomegalovirus, as used in adenovirus vectors (  Fig. 4  ), 
or Rous sarcoma virus, which is more potent in cardiomyocytes. 
  Immunoﬂ  uorescence staining 
  After cardiomyocytes were ﬁ  xed in 4% PFA for 15 min at room tempera-
ture, nonspeciﬁ  c binding was blocked for at least 1 h with blocking buffer 
(PBS   ×   1, 50 mM glycine, 2% BSA, 2% goat serum, and 0.01% sodium-
azide). Next, cells were incubated overnight at 4  °  C with primary antibod-
ies (  Table I  ) in washing buffer (blocking buffer diluted 1:10 in PBS   ×   1), and 
immune complexes were detected with Alexa 488, Alexa 594 (Invitrogen), 
was disintegrated, staining for the V5 epitope on N2  ICD   became 
cytoplasmic, which indicates cytosolic relocalization of the pro-
tein (Fig. S2 G). 
  Notch in ventricular development 
and disease 
  We evaluated Notch2 because it is the predominant isoform pres-
ent on cardiomyocytes while the chamber myocardium is grow-
ing during mid-to-late gestation. An implication of our data is that 
Notch2 in the fetal heart might prevent differentiation and sustain 
replication of newly formed cardiomyocytes to permit the dra-
matic growth of ventricular myocardium, which expresses Jag-
ged1, Jagged2, and Notch2 in overlapping patterns (  Loomes 
et al., 2002  ;   Rutenberg et al., 2006  ;   Grego-Bessa et al., 2007  ; 
  Niessen and Karsan, 2007  ). Although the phenotypes caused by 
systemic deletions of Notch signaling components are consistent 
with such a model, the cardiac defects are likely to also be caused 
by secondary consequences of the loss of Notch, such as in the 
endocardium (  Grego-Bessa et al., 2007  ). All 3D-type cyclins are 
present in the developing heart, and, interestingly, the triple 
knockout mouse exhibited severely hypoplastic ventricular myo-
cardium and died by embryonic day 16.5 (  Kozar et al., 2004  ). 
Thus, we speculate that myocyte-autonomous Notch  –  cyclin D 
interactions might underlie ventricular growth. Myocardial con-
ditional knockouts of RBP-J  k   and Notch2 using appropriate Cre 
lines are being analyzed to address this issue. 
  An important implication of this study is that Notch might 
play a similar role after myocardial injury by sustaining prolif-
  Figure 9.       Summary of Notch2-induced cell cycle entry.   RBP-J      –  dependent 
transcription leads to accumulation of cyclin D1 in the cytosol. Notch ICD 
regulates entry into the cell cycle by controlling nuclear localization of 
cyclin D1 independently of RBP-J    .     JCB • VOLUME 183 • NUMBER 1 • 2008  140
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  After immunostaining, the cultures were mounted in Dako medium 
(Dako), and wide-ﬁ  eld images were acquired at room temperature on an 
inverted ﬂ  uorescence microscope (SX71; Olympus) with a 20  ×   0.40 NA 
or 40  ×   0.60 NA objective (Olympus) using a camera (C47425; Hama-
matsu) and MetaMorph version 6 acquisition software (MDS Analytical 
Technologies). For high-magniﬁ   cation and confocal images, cells were 
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ﬁ  eld images were acquired at room temperature on a microscope (Axio-
plan; Carl Zeiss, Inc.) with a 40  ×   0.74 NA or 63  ×   1.4 NA objective (Carl 
Zeiss, Inc.) using a Spot RT camera (Diagnostic Instruments, Inc.) and 
MetaMorph version 6 acquisition software. Confocal images were ac-
quired at room temperature on a multiphoton microscope (Radiance 
2100/AGR-3Q; Bio-Rad Laboratories) with a 40  ×   0.6 NA objective using 
LS2000 software (Bio-Rad Laboratories). Images are presented after digi-
tal adjustment of curve levels (gamma) to maximize signal. In all cases, 
exposure times and digital manipulation were the same for control and 
experimental samples. Fluorochromes and color are as indicated in the 
ﬁ  gure legends. 
  Western blot analysis 
  Lysates were prepared by incubating cells in 20 mM Tris HCl, pH 8, 137 
mM NaCl, 10% glycerol, 1% NP-40, and 10 mM EDTA on ice for 15 min, 
cleared by centrifugation, frozen in dry ice, and thawed at 4  °  C. 20   μ  g per 
lane of lysates were resolved by SDS-PAGE (4  –  12% or 8  –  16% gradient 
gels; Invitrogen), transferred onto polyvinylidene ﬂ   uoride membranes 
(Immobilon-P; Millipore), and probed overnight at 4  °  C with primary anti-
bodies; speciﬁ  c bands were then detected using HRP-conjugated secondary 
antibodies (1:20,000; GE Healthcare) and the ECL detection system (GE 
Healthcare). Primary antibodies are listed in   Table I  . 
  Cell cycle analysis 
  The cell cycle proﬁ  le of cardiac cells was analyzed as described previously 
(  Schmid et al., 1991  ). In brief, cells were ﬁ  xed for 1 h at 4  °  C with 0.25% 
PFA and then permeabilized for 15 min at 37  °  C with 0.2% Tween 20 before 
incubation with MF20 and secondary antibodies (Alexa 488  –  conjugated 
anti  –  mouse Ig) diluted 1:100 in FACS buffer (PBS with 1% goat serum and 
0.1% NaN  3  ). Cells were then stained with 10   μ  g/ml propidium iodide in 
FACS buffer supplemented with 500   μ  g/ml of RNAase A. 
  Online supplemental material 
  Fig. S1 shows the incidences of cell cycle entry in response to N2  ICD  , PHE, 
and 10% FCS. Fig. S2 shows the presence of mitotic ﬁ  gures in cardiomyo-
cytes treated with Ad-N2  ICD  . Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.200806104/DC1. 
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  Table I.       Antibodies and dilutions used for immunoﬂ  uorescent detection of proteins   
Antibody Dilution Source
Anti-muscle myosins, MF20 mouse Ab 1:100 Developmental Studies Hybridoma Bank, University of Iowa
Anti  –      -actinin, mouse Ab 1:200 Sigma-Aldrich
Anti  –  phospho-His3 (Ser10) rabbit Ab 1:100 Millipore
Anti-AuroraB rabbit Ab 1:250 BD Biosciences
Anti-Ki67 rabbit Ab 1:100 Novus Biologicals
Anti-p21 mouse Ab 1:100 Millipore
Anti-p57 rabbit Ab 1:200 Santa Cruz Biotechnology, Inc.
Anti-V5 mouse Ab 1:200 Invitrogen
Anti-Notch2 rabbit Ab 1:200 Abcam
Anti-cyclin D1 rabbit Ab 1:200 W. Jiang (Burnham Institute for Medical Research, La Jolla, CA)
Anti  –  phospho-Rb (Ser807/811) rabbit Ab 1:200 Cell Signaling Technology
Anti  –  c-myc mouse Ab 1:100 Santa Cruz Biotechnology, Inc.141  NOTCH SUSTAINS CARDIOMYOCYTE CELL CYCLE   • Campa et al. 
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